AR244217A1 - Procedimiento para preparar derivados de acidos 3-amino-4-oxo-2,3,4,5-tetrahidro-1,5-benzotiazepin-5-alcanoicos(c2-c3) - Google Patents

Procedimiento para preparar derivados de acidos 3-amino-4-oxo-2,3,4,5-tetrahidro-1,5-benzotiazepin-5-alcanoicos(c2-c3)

Info

Publication number
AR244217A1
AR244217A1 AR84296356A AR29635684A AR244217A1 AR 244217 A1 AR244217 A1 AR 244217A1 AR 84296356 A AR84296356 A AR 84296356A AR 29635684 A AR29635684 A AR 29635684A AR 244217 A1 AR244217 A1 AR 244217A1
Authority
AR
Argentina
Prior art keywords
anoicos
benzothiazepin
alk
tetrahydro
oxo
Prior art date
Application number
AR84296356A
Other languages
English (en)
Spanish (es)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1983/000342 external-priority patent/WO1985001730A1/ja
Priority claimed from PCT/JP1984/000119 external-priority patent/WO1985004402A1/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of AR244217A1 publication Critical patent/AR244217A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AR84296356A 1983-04-22 1984-04-18 Procedimiento para preparar derivados de acidos 3-amino-4-oxo-2,3,4,5-tetrahidro-1,5-benzotiazepin-5-alcanoicos(c2-c3) AR244217A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP1983/000127 WO1984004306A1 (fr) 1983-04-22 1983-04-22 C0mposes cycliques a 7 membres fusionnes et leur procede de preparation
PCT/JP1983/000342 WO1985001730A1 (fr) 1983-10-13 1983-10-13 Composes cycliques fusionnes a 7 membres et leur procede de preparation
PCT/JP1984/000119 WO1985004402A1 (fr) 1984-03-24 1984-03-24 Composes cycliques fusionnes a sept membres et leur procede de preparation

Publications (1)

Publication Number Publication Date
AR244217A1 true AR244217A1 (es) 1993-10-29

Family

ID=13789981

Family Applications (1)

Application Number Title Priority Date Filing Date
AR84296356A AR244217A1 (es) 1983-04-22 1984-04-18 Procedimiento para preparar derivados de acidos 3-amino-4-oxo-2,3,4,5-tetrahidro-1,5-benzotiazepin-5-alcanoicos(c2-c3)

Country Status (6)

Country Link
JP (1) JPS59205372A (th)
AR (1) AR244217A1 (th)
DK (1) DK196884A (th)
SU (1) SU1526583A3 (th)
WO (1) WO1984004306A1 (th)
ZA (1) ZA842926B (th)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608283A (ja) * 1983-06-29 1985-01-17 Mitsui Toatsu Chem Inc ベンゾチアゼピン誘導体およびその製造方法
JPS60174775A (ja) * 1984-02-21 1985-09-09 Mitsui Toatsu Chem Inc ベンゾチアゼピン誘導体
JPS60239475A (ja) * 1984-05-15 1985-11-28 Mitsui Toatsu Chem Inc 置換ベンゾチアゼピン誘導体
JPS61148171A (ja) * 1984-12-21 1986-07-05 Mitsui Toatsu Chem Inc ベンゾチアゼピン誘導体
US4692522A (en) * 1985-04-01 1987-09-08 Merck & Co., Inc. Benzofused lactams useful as cholecystokinin antagonists
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
WO1998041510A1 (en) * 1997-03-14 1998-09-24 Shionogi & Co., Ltd. Novel benzolactam derivatives and medicinal compositions comprising the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460579A (en) * 1983-02-28 1984-07-17 E. R. Squibb & Sons, Inc. Thiazine and thiazepine containing compounds

Also Published As

Publication number Publication date
JPH0564144B2 (th) 1993-09-14
WO1984004306A1 (fr) 1984-11-08
ZA842926B (en) 1984-12-24
JPS59205372A (ja) 1984-11-20
DK196884D0 (da) 1984-04-17
SU1526583A3 (ru) 1989-11-30
DK196884A (da) 1984-10-23

Similar Documents

Publication Publication Date Title
PL250524A1 (en) Process for preparing derivatives of 2,2'-imino-bisethanol
AR242953A1 (es) Procedimiento para preparar nuevos derivados sustituidos de benzamida.
LTIP1625A (en) Process for the preparation of (1h-azol-1-ylmethyl)substituted benzotriazole derivatives
PT80976A (en) Process for the preparation of benzimidazole derivatives
PT79925A (en) Process for preparing 6-substituted-4-dialkylaminotetrahydrobenz<c,d>indoles
DE3477566D1 (en) Process for the preparation of beta-hydroxyethyl-1,2,4-triazole derivatives
KR950010075B1 (en) Process for the preparation of 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives
HU901428D0 (en) Process for the preparation of 5-substituted 1,4-dihydro-4-oxo-naphthiridine-3-carboxylic acid derivatives
GR80671B (en) Process for the preparation of imidazoline derivatives
PT81987B (en) Process for preparing antihypertensive dihydropiridine derivatives
DE3470160D1 (en) Method for the preparation of beta-hydroxy-ethyl-(1,2,4-triazole) derivatives
DE3476381D1 (en) Process for the preparation of pentadienol derivatives
PT79779A (en) Process for preparing novel 1,4-naphtoquinone derivatives
PT79630A (en) Process for the preparation of 1,2,4-oxo(tio)diazoline-3-one derivatives
PT80566A (en) Process for preparing 4-<2-(dialkylamino)ethyl>isatins
PT82873B (en) Process for the preparation of tetrahydropirido(1,2-2)indole derivatives
GB8321943D0 (en) Preparation of 2,3-dihydro-benzopyranone derivatives
GB2137987B (en) Process for the preparation of 3,4-dihydro-2-substituted-2h-1,2-benzothiazine-carboxylic acid 1,1-dioxide derivatives
YU173585A (en) Process for obtaining derivatives of 3,4-diazole
HUT34003A (en) Process for preparing 4,4'-alkylene-dipiperidine derivatives
GB2165242B (en) Process for the preparation of 1, 2-benzoxathiine derivatives
GB2146331B (en) Process for the preparation of dihydroaryloxy-alkylamino-1,2,4-triazole derivatives
PT81633B (en) Process for the preparation of 1,4-dihydropiridine derivatives
HUT38933A (en) Process for preparing 4-substituted-pyrimido <6,1-a> isoquinoline-derivatives
PT81554B (en) Process for preparing substituted naphtopyran derivatives